Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry

BACKGROUND: Belimumab is approved for active, autoantibody‐positive systemic lupus erythematosus (SLE) and lupus nephritis, but limited data exist regarding its use in pregnancy. The Belimumab Pregnancy Registry (BPR, GSK Study BEL114256; NCT01532310) was created to evaluate pregnancy and infant out...

Descripción completa

Detalles Bibliográficos
Autores principales: Juliao, Patricia, Wurst, Keele, Pimenta, Jeanne M., Gemzoe, Kim, Landy, Helain, Moody, M. Anthony, Tilson, Hugh, Covington, Deborah, Moore, Tammy, Marino, Rebecca, Gilbride, Jennifer, Liu, Andrew, Meizlik, Paige, Petri, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092734/
https://www.ncbi.nlm.nih.gov/pubmed/36177676
http://dx.doi.org/10.1002/bdr2.2091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092734/
https://www.ncbi.nlm.nih.gov/pubmed/36177676
http://dx.doi.org/10.1002/bdr2.2091

Ejemplares similares